# K213652: Cresilon Hemostatic Gel, CHG, Cresilon Hemostatic Gel (CHG)

- Pathway: 510(k) (Traditional)
- Applicant: Cresilon, Inc.
- Decided: Jun 28, 2023 after 586 days
- Product code: QSY (Hemostatic Wound Dressing Without Thrombin Or Other Biologics)
- Device class: U
- Recalls of this device: none
- Data: FDA decisions to Oct 25, 2026; recalls to Oct 12, 2026

## Lineage
Longest line of descent: 6 generations back to K972914 (1997). 8 ancestors in all.
1 later device descends from it; 1 cites it directly.
0 of 10 devices in its family (counting itself) have a Class I recall.

## Predicates on the family tree (from the FDA summary)
- K180152: gel-e Flex, Gel-E, Inc. (2018) Summary page 4.

## Most influential descendants
- K253609: TRAUMAGEL® 2.0 Hemostatic Gel (2025), 0 descendants of its own

## Indications for use
Cresilon Hemostatic Gel™ (CHG™) is a hemostatic gel for external use only. Cresilon Hemostatic Gel™ (CHG™) is indicated for the local management of bleeding wounds such as minor cuts, minor lacerations, and minor abrasions.

Source page: https://510kreport.com/device/K213652
Methodology: https://510kreport.com/methodology